Results 31 to 40 of about 1,574,756 (175)

Clinical profile of prosthetic heart valve thrombosis and outcome analysis of fibrinolytic therapy versus surgical management: A single-center experience

Heart India, 2020
Context: The main aim of the study is to find out efficacy, outcomes, and complications of thrombolytic therapy and surgery for obstructive prosthetic heart valve thrombosis (PHVT).
Zeeshan Mansuri, Vishal Sharma, Sharad Jain, Jayesh Prajapati, Sanjeev Bhatia, Krutika Patel   +5 more
doaj   +1 more source

Newer fibrinolytic agents in patients with acute myocardial infarction

, 1986
Fibrinolytic agents with higher specificity for fibrin in the thrombi and little systemic activation of the fibrinolytic system have been developed and tested in preliminary clinical trials of patients with acute myocardial infarction.
E. Faioni, P. M. Mannucci, Elena Faioni, Pier Mannuccio Mannucci   +3 more
core   +1 more source

Fibrinolytic therapy

, 2018
Fibrinolytic agents are able to reopen blood vessels that are occluded by a fresh thrombus. Urokinase, streptokinase, and streptokinase derivatives were the first effective agents. Recombinant plasminogen activators became available and they are specific
Freek W. A. Verheugt
core   +1 more source

The comparison of streptokinase, an old agent, versus reteplase for the re-tunnellisation of blocked cuffed haemodialysis catheter [PDF]

Scripta Medica
Background/Aim: Catheter occlusion is the most common complication occurring in patients with end-stage renal disease (ESRD) who undergo haemodialysis. The management typically involves the use of local fibrinolytic agents. However, with the emergence of
Saroukhani Abbas, Omid Soheil
doaj   +1 more source

Acute Kidney Injury After Mechanical Thrombectomy for Stroke in Patients With Pre‐Existing Renal Impairment

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives Acute kidney injury (AKI) is a common but often underrecognized complication in ischemic stroke patients undergoing mechanical thrombectomy, particularly among those with pre‐existing renal impairment. This study evaluated the incidence, risk factors, and clinical impact of AKI in this high‐risk population.
Michał Borończyk, Marcel Pilarek, Emilia Jaworska, Natalia Kardas, Oliwia Barnaś, Julia Woźniak, Iga Machała, Julia Węgrzynek‐Gallina, Joanna Siuda, Anna Hawrot‐Kawecka, Anetta Lasek‐Bal   +10 more
wiley   +1 more source

Magnetic Micro‐ and Nanorobots for Precision Thrombolysis: Design Strategies and Translational Challenges

Advanced Robotics Research, EarlyView.
Micro‐ and nanorobots for targeted thrombolysis. This perspective elaborates on the clinical indication of blood clot disorders and current limitations for treatment. As a novel, alternative solution, micro‐ and nanorobots can be used to treat and break down thrombi.
Joshua M. Mesfin, Yimo Yan, Nikola Cesarovic, Simone Schuerle   +3 more
wiley   +1 more source

Fibrinolytic therapy for parapneumonic empyema during pregnancy

, 2012
Pneumonia and parapneumonic complicated effusion during pregnancy is uncommon but poses potentially serious risks to both mother and fetus. Enzymatic debridement of the pleural cavity with fibrinolytic agents is a noninvasive option that can facilitate ...
Ulutas, Hakki, Doru, Ihsan, Erdal Yekeler, Kuzucu, Akin, Ihsan Doru, Hakki Ulutas, Zafer Hasan Ali Sak, Akin Kuzucu, Yekeler, Erdal, Sak, Zafer Hasan Ali   +9 more
core   +1 more source

Penicillium citrinum CFAM 521 Isolated From the Amazon Region: A Novel Source of a Fibrinolytic Enzyme

International Journal of Microbiology
Fibrinolytic agents are essential in treating thrombosis, playing a critical role in improving survival rates in cardiovascular diseases. Microbial fibrinolytic proteases have emerged as promising alternatives due to their affordability, specificity ...
Thayana Cruz de Souza, Marcos Gustavo Araujo Schwarz, Daniela Marinho da Silva, Carolina Rabelo Maia, Cláudia Patrícia Mendes de Araújo, Antônio Alcirley da Silva Balieiro, Luiz Antonio de Oliveira, Wim Maurits Sylvain Degrave, Ormezinda Celeste Cristo Fernandes, Leila Mendonça-Lima   +9 more
doaj   +1 more source

Does thrombolytic therapy harm or help in ST elevation myocardial infarction (STEMI) caused by the spontaneous coronary dissection? [PDF]

Vojnosanitetski Pregled, 2015
Introduction. Spontaneous coronary artery dissection (SCAD) is a very rare disease with poor prognosis. It mainly affects young women free of risk factors for coronary artery disease (CAD) and women during the peripartum period.
Jović Zoran, Obradović Slobodan, Đenić Nemanja, Mladenović Zorica, Đurić Predrag, Spasić Marijan, Tavčiovski Dragan   +6 more
doaj   +1 more source

Cangrelor Dosing, Administration, and Clinical Outcomes for Patients Undergoing Complex and High‐Risk Percutaneous Coronary Interventions

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Cangrelor reduces thrombotic events in patients undergoing percutaneous coronary intervention (PCI), with the advantage of rapid onset and offset. However, premature discontinuation may increase the risk of acute thrombosis for patients undergoing complex/high‐risk PCI (CHIP).
Siyu Ma, Wendy Y. Cheng, Yinong Liang, Josephine Bryar, Gwyneth Wei, Joshua D. Niznik, Christina Yin, Sue Liu‐Yi, Jimmy L. Kerrigan   +8 more
wiley   +1 more source